In 2013, Glaucoma Research Foundation received a $3 million bequest, the largest in its history, from Henry Adolph Sutro, DDS, of Oakland, California.
ZIOPTAN is the first preservative-free prostaglandin analog ophthalmic solution. It is approved for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
